Nana

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data roche-pushes-for-earlier-use-of-lunsumio-in-follicular-lymphoma-with-promising-phase-iii-data

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

Nana September 18, 2026

Basel, Switzerland – [Insert Date] – Roche is actively seeking to expand the therapeutic landscape for its...

Medtronic Advances Robotic Surgery Capabilities: FDA Clears LigaSure RAS Maryland Device for Hugo System medtronic-advances-robotic-surgery-capabilities-fda-clears-ligasure-ras-maryland-device-for-hugo-system

Medtronic Advances Robotic Surgery Capabilities: FDA Clears LigaSure RAS Maryland Device for Hugo System

Nana September 18, 2026

In a significant move to strengthen its position in the competitive robotic-assisted surgery (RAS) market, Medtronic has...

Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Partnership groepsfoto-dialoog VWS BZ - WHO

Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Partnership

Nana September 18, 2026

The Hague, Netherlands – On April 10, 2024, the World Health Organization (WHO) and the Kingdom of...

The Biotech IPO Resurgence: Electra Therapeutics Leads a New Wave of Public Market Confidence the-biotech-ipo-resurgence-electra-therapeutics-leads-a-new-wave-of-public-market-confidence

The Biotech IPO Resurgence: Electra Therapeutics Leads a New Wave of Public Market Confidence

Nana September 18, 2026

By Gwendolyn Wu | September 17, 2026 The biotechnology sector, which spent much of the last three...

More Than Service: The Transformative Power of Sisterhood in the Fight Against Breast Cancer more-than-service-the-transformative-power-of-sisterhood-in-the-fight-against-breast-cancer

More Than Service: The Transformative Power of Sisterhood in the Fight Against Breast Cancer

Nana September 18, 2026

By Severina Ware, NBCF Director of Volunteer Services As the Director of Volunteer Services at the National...

Finding Sanctuary in the Infusion Suite: The Radical Power of Kind Care finding-sanctuary-in-the-infusion-suite-the-radical-power-of-kind-care

Finding Sanctuary in the Infusion Suite: The Radical Power of Kind Care

Nana September 18, 2026

Introduction: Reimagining the Clinical Experience In the high-stakes environment of oncology, the discourse surrounding treatment is often...

The AI Frontier: How Sheba Medical Center Became OpenAI’s First Global Healthcare Partner the-ai-frontier-how-sheba-medical-center-became-openais-first-global-healthcare-partner

The AI Frontier: How Sheba Medical Center Became OpenAI’s First Global Healthcare Partner

Nana September 17, 2026

In the rapidly evolving landscape of medical technology, Israel’s Sheba Medical Center has carved out a position...

Arrowhead Pharmaceuticals Achieves Landmark Dual-Gene Silencing with ARO-DIMER-PA, Promising New Era for Cardiovascular Disease Treatment arrowhead-pharmaceuticals-achieves-landmark-dual-gene-silencing-with-aro-dimer-pa-promising-new-era-for-cardiovascular-disease-treatment

Arrowhead Pharmaceuticals Achieves Landmark Dual-Gene Silencing with ARO-DIMER-PA, Promising New Era for Cardiovascular Disease Treatment

Nana September 17, 2026

San Diego, CA – [Insert Date] – Arrowhead Pharmaceuticals has announced significant interim top-line results from its...

Axoltis Pharma Navigates ALS Development Challenges with Promising Exploratory Data Amidst Stricter Regulatory Landscape axoltis-pharma-navigates-als-development-challenges-with-promising-exploratory-data-amidst-stricter-regulatory-landscape

Axoltis Pharma Navigates ALS Development Challenges with Promising Exploratory Data Amidst Stricter Regulatory Landscape

Nana September 16, 2026

Boston, MA – [Insert Date] – The relentless pursuit of effective treatments for Amyotrophic Lateral Sclerosis (ALS)...

The Race for Innovation: FDA Launches “Operation Trialblazer” to Stem the Tide of Overseas Clinical Trials the-race-for-innovation-fda-launches-operation-trialblazer-to-stem-the-tide-of-overseas-clinical-trials

The Race for Innovation: FDA Launches “Operation Trialblazer” to Stem the Tide of Overseas Clinical Trials

Nana September 16, 2026

In a strategic move to reclaim its status as the world’s premier hub for pharmaceutical innovation, the...

Roche Pushes for Earlier Use of Lunsumio in Follicular Lymphoma with Promising Phase III Data

Medtronic Advances Robotic Surgery Capabilities: FDA Clears LigaSure RAS Maryland Device for Hugo System

Strengthening the Global Health Architecture: A Deep Dive into the WHO-Netherlands Strategic Partnership

The Biotech IPO Resurgence: Electra Therapeutics Leads a New Wave of Public Market Confidence

More Than Service: The Transformative Power of Sisterhood in the Fight Against Breast Cancer

Finding Sanctuary in the Infusion Suite: The Radical Power of Kind Care

The AI Frontier: How Sheba Medical Center Became OpenAI’s First Global Healthcare Partner

Arrowhead Pharmaceuticals Achieves Landmark Dual-Gene Silencing with ARO-DIMER-PA, Promising New Era for Cardiovascular Disease Treatment

Axoltis Pharma Navigates ALS Development Challenges with Promising Exploratory Data Amidst Stricter Regulatory Landscape

The Race for Innovation: FDA Launches “Operation Trialblazer” to Stem the Tide of Overseas Clinical Trials

You may have missed

Breakthrough in Breast Cancer: Penn Scientists Uncover Path to Eradicate Dormant Cells, Prevent Recurrence

MHRA Embraces Contextual Safety Assessments for Clinical Trial Applications, Bolstering UK’s Regulatory Agility

A Beacon of Hope: Shelly’s Journey Through Breast Cancer, Illuminated by Patient Navigation

Bridging the Gap in Women’s Health: CAKES Body Extends Landmark Partnership with BCRF to Fund Research for Younger Women